L-Carnitine
Fat-to-mitochondria shuttle.
- Lyophilised powderFormat
- 1–6 weeksVial coverage
- 3 mL BAC waterReconstitution
What it is, in plain language
L-Carnitine is an amino-acid derivative critical to fatty-acid metabolism. It functions as the transporter that moves long-chain fatty acids across the mitochondrial membrane, where they can be oxidised for energy. Endogenous synthesis is generally adequate, but research and athletic protocols supplement to support fat oxidation, exercise capacity, and recovery.
Unlike the peptides in the AEON line, L-Carnitine is an amino-acid derivative, not a signalling molecule. The injectable format is favoured in research contexts for its bioavailability advantage over oral.
Without adequate carnitine, fatty-acid oxidation is rate-limited regardless of substrate availability — the shuttle is the bottleneck.
How it works
Conjugates with long-chain fatty acids to form acyl-carnitines, which cross the inner mitochondrial membrane. Inside the mitochondrion, the fatty acid is released for beta-oxidation. Without adequate carnitine, fatty-acid oxidation is rate-limited regardless of substrate availability.
What the literature shows
Human studies report modest improvements in fat oxidation, exercise capacity, and recovery markers with L-Carnitine supplementation, particularly in deficient or borderline-deficient subjects.
Effects are more pronounced when paired with training and adequate fatty-acid availability — L-Carnitine does not produce fat loss in the absence of caloric deficit and movement. It is a permissive cofactor, not a driver.
Protocol reference
Common research-grade reference figures. Not medical advice — every protocol must be reviewed against the latest published literature and your study design.
Continuous use is common, but rotation (8–12 weeks on, 2–4 weeks off) avoids adaptation. Annual ceiling: continuous use is acceptable, but periodic washouts are advisable. Pairs naturally with MOTS-c (metabolic parallel) and NAD+ (energy parallel). Compatible with all other lines without overlap.
3 mL BAC → 200 mg/mL. Draw 0.5 mL = 100 mg; 1.0 mL = 200 mg. Larger reconstitution volume preferred for injection comfort.
Lyophilised vial: room temperature short-term, refrigerator long-term. Reconstituted: refrigerate; use within 28 days when reconstituted with bacteriostatic water.
Common questions
Injectable vs oral L-Carnitine — what does the research compare?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Does L-Carnitine actually burn fat?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Why is it paired with training rather than dosed solo?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
L-Carnitine vs Acetyl-L-Carnitine — what's the difference?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Can L-Carnitine run alongside the GLP-1 protocols?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Stack partners
NAD+ 500mg
Nicotinamide adenine dinucleotide · cellular energy research
View product →MOTS-c 20mg
Mitochondrial-derived peptide · metabolic research
View product →Semaglutide 20mg
GLP-1 receptor agonist · weight & metabolic research
View product →